Kayla Catalfamo

Roswell Park Comprehensive Cancer Center — United States

Medicine · Health Sciences

4h-index70citations32works1.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(8), Gastric Cancer Management and Outcomes(8), Breast Cancer Treatment Studies(6), Esophageal Cancer Research and Treatment(6), Cancer Risks and Factors(5)

Publications32 total

Abstract B047: PC TEACH, a cancer prevention intervention: Assessing the implementation and adoption of evidence-based strategies to increase human papillomavirus (HPV) vaccination delivery in rural primary care settings
Cancer Epidemiology Biomarkers & Prevention·2025
Effects of Neighborhood Deprivation Index on Survival in Gastroesophageal Adenocarcinoma
Healthcare·2025· 1 citedOpen Access
Effects of Neighborhood Deprivation Index on Survival in Gastroesophageal Adenocarcinoma
Preprints.org·2025Open Access
Tumor-derived factor B drives tumor growth and anti-PD-1 resistance in STK11-mutant lung adenocarcinoma
Immunobiology·2025· 1 citedOpen Access
455P Effects of neighborhood deprivation index on survival in upper gastrointestinal cancers
Annals of Oncology·2025Open Access
Area deprivation index and breast cancer outcomes among patients in Western New York
Breast Cancer Research and Treatment·2025Open Access
Abstract P5-02-04: Factors Predicting Transition to Independent Grants among NIH K awardees in Breast Oncology
Clinical Cancer Research·2025
Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: A Phase II Study
Cancer Medicine·2025Open Access
Effects of neighborhood deprivation index on survival in gastric cancers.
Journal of Clinical Oncology·2025
Prognostic immune markers in esophageal cancer patients managed with trimodal therapy
Cancer Immunology Immunotherapy·2025· 1 citedOpen Access
Prognostic Immune Markers in Esophageal Cancer Patients Managed with Trimodal Therapy
International Journal of Radiation Oncology*Biology*Physics·2024
Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience
Clinical Breast Cancer·2024· 16 citedOpen Access
Evaluation of safety outcomes between nivolumab regimens with differing dosing patterns
Journal of Oncology Pharmacy Practice·2024· 2 citedOpen Access
Health-related quality of life outcomes reporting associated with FDA approvals in haematology and oncology
BMJ Oncology·2024· 6 citedOpen Access
Real-world efficacy and adverse events of neoadjuvant immunotherapy in patients with early-stage triple-negative breast cancer: A multi-center experience.
Journal of Clinical Oncology·2024· 1 cited
Access to germline testing and prevalence of somatic mutations in patients with breast cancer from disadvantaged areas: A single-center study.
Journal of Clinical Oncology·2024
Abstract PO4-09-06: Area Deprivation Index (ADI) among Patients with Breast Cancer in Buffalo
Cancer Research·2024
Area Deprivation Index (ADI) among Patients with Breast Cancer in Buffalo
International Journal of Cancer Care and Delivery·2023Open Access
Racial and Ethnic Disparity in Preoperative Chemosensitivity and Survival in Patients With Early-Stage Breast Cancer
JAMA Network Open·2023· 12 citedOpen Access
Indigenizing and Ruralizing NCI Screen to Save Program: Resources, Optimizing Outreach, Teaching, Science (ROOTS)
Journal of Cancer Education·2023· 4 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Kristopher Attwood(25), Arya Mariam Roy(10), Shipra Gandhi(10), Archit Patel(8), Malak Alharbi(8), Han Yu(7), Ankita Kapoor(6), Song Yao(6), Thaer Khoury(4), Sawyer Bawek(4), Deepak Vadehra(4), Sarbajit Mukherjee(4), Angela R. Omilian(4), Ellis Levine(4), Jayasree Krishnan(3), Angel Mier-Hicks(3), Shipra Gandhi(3), Mrinalini Ramesh(3), Beas Siromoni(3), Moshim Kukar(3)